Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
25.99B | 23.62B | 22.37B | 20.87B | 18.47B | 20.01B | Gross Profit |
10.54B | 9.79B | 9.57B | 8.99B | 7.88B | 8.02B | EBIT |
2.53B | 2.44B | 2.64B | 2.89B | 2.52B | 2.31B | EBITDA |
3.26B | 3.09B | 3.29B | 3.67B | 3.26B | 2.91B | Net Income Common Stockholders |
1.74B | 1.69B | 1.92B | 2.11B | 1.83B | 1.53B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.10B | 13.41B | 16.17B | 12.40B | 11.69B | 8.65B | Total Assets |
40.95B | 42.82B | 40.84B | 36.89B | 34.69B | 31.93B | Total Debt |
0.00 | 8.86M | 7.40M | 1.16M | 2.89M | 4.59M | Net Debt |
-11.10B | -13.41B | -16.16B | -12.40B | -11.69B | -8.64B | Total Liabilities |
5.92B | 8.40B | 8.26B | 5.85B | 5.49B | 4.46B | Stockholders Equity |
34.63B | 34.07B | 32.28B | 30.79B | 28.96B | 27.23B |
Cash Flow | Free Cash Flow | ||||
0.00 | -225.33M | 4.30B | 1.24B | 3.34B | 3.37B | Operating Cash Flow |
0.00 | 119.09M | 4.61B | 2.08B | 3.49B | 3.56B | Investing Cash Flow |
0.00 | -2.52B | -299.61M | -1.34B | -1.99B | -1.48B | Financing Cash Flow |
0.00 | -1.07B | -695.63M | -763.64M | -561.05M | -946.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥32.35B | 8.34 | 10.31% | 3.47% | 4.01% | 5.69% | |
79 Outperform | ¥20.35B | 12.02 | 3.34% | 15.17% | 36.74% | ||
73 Outperform | $3.74T | 28.98 | 27.22% | 0.01% | 27.88% | 47.09% | |
69 Neutral | ¥11.16B | 19.43 | 2.64% | -10.39% | -43.57% | ||
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% | |
65 Neutral | $277.50B | 25.82 | 4.03% | 3.21% | 2.87% | 2.48% | |
64 Neutral | ¥39.62B | 19.61 | 3.19% | 3.70% | 6.62% | -79.43% |